Answer
Enoxaparin sodium reduces blood clotting through antithrombin III–mediated inhibition of factor Xa and, to a lesser extent, factor IIa (thrombin), with additional antithrombin III–dependent inhibition of other coagulation factors such as VIIa.
Sources for this answer
- Clexane Forte SyringesSANOFI · emc · SmPC §5.1 Pharmacodynamic properties · Version 23Document updated
Sources checked